Literature DB >> 26419901

Suppressing cAMP response element-binding protein transcription shortens the duration of status epilepticus and decreases the number of spontaneous seizures in the pilocarpine model of epilepsy.

Xinjian Zhu1,2, Deepti Dubey3, Camilo Bermudez1, Brenda E Porter1,3,4.   

Abstract

OBJECTIVE: Current epilepsy therapies directed at altering the function of neurotransmitter receptors or ion channels, or release of synaptic vesicles fail to prevent seizures in approximately 30% of patients. A better understanding of the molecular mechanism underlying epilepsy is needed to provide new therapeutic targets. The activity of cyclic AMP (cAMP) response element-binding protein (CREB), a major transcription factor promoting CRE-mediated transcription, increases following a prolonged seizure called status epilepticus. It is also increased in the seizure focus of patients with medically intractable focal epilepsy. Herein we explored the effect of acute suppression of CREB activity on status epilepticus and spontaneous seizures in a chronic epilepsy model.
METHODS: Pilocarpine chemoconvulsant was used to induce status epilepticus. To suppress CREB activity, a transgenic mouse line expressing an inducible dominant negative mutant of CREB (CREB(IR) ) with a serine to alanine 133 substitution was used. Status epilepticus and spontaneous seizures of transgenic and wild-type mice were analyzed using video-electroencephalography (EEG) to assess the effect of CREB suppression on seizures.
RESULTS: Our findings indicate that activation of CREB(IR) shortens the duration of status epilepticus. The frequency of spontaneous seizures decreased in mice with chronic epilepsy during CREB(IR) induction; however, the duration of the spontaneous seizures was unchanged. Of interest, we found significantly reduced levels of phospho-CREB Ser133 upon activation of CREB(IR) , supporting prior work suggesting that binding to the CRE site is important for CREB phosphorylation. SIGNIFICANCE: Our results suggest that CRE transcription supports seizure activity both during status epilepticus and in spontaneous seizures. Thus, blocking of CRE transcription is a novel target for the treatment of epilepsy. Wiley Periodicals, Inc.
© 2015 International League Against Epilepsy.

Entities:  

Keywords:  CyclicAMP response element-mediated transcription; Epilepsy; Pilocarpine; Spontaneous seizures; Status epilepticus; cAMP response element-binding

Mesh:

Substances:

Year:  2015        PMID: 26419901      PMCID: PMC6689408          DOI: 10.1111/epi.13211

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  9 in total

1.  Inhibition of Acid Sensing Ion Channel 3 Aggravates Seizures by Regulating NMDAR Function.

Authors:  Qian Cao; Zhe-Man Xiao; Xi Wang; Chao Weng; Man Ding; Fan Zhu; Zu-Neng Lu
Journal:  Neurochem Res       Date:  2018-05-07       Impact factor: 3.996

2.  Increased Expression of Brain-Derived Neurotrophic Factor Transcripts I and VI, cAMP Response Element Binding, and Glucocorticoid Receptor in the Cortex of Patients with Temporal Lobe Epilepsy.

Authors:  G A Martínez-Levy; L Rocha; F Rodríguez-Pineda; M A Alonso-Vanegas; A Nani; R M Buentello-García; M Briones-Velasco; D San-Juan; J Cienfuegos; C S Cruz-Fuentes
Journal:  Mol Neurobiol       Date:  2017-05-19       Impact factor: 5.590

3.  Inhibition of AKT/GSK3β/CREB Pathway Improves the Responsiveness to AMPA Receptor Antagonists by Regulating GRIA1 Surface Expression in Chronic Epilepsy Rats.

Authors:  Ji-Eun Kim; Duk-Shin Lee; Hana Park; Tae-Hyun Kim; Tae-Cheon Kang
Journal:  Biomedicines       Date:  2021-04-14

4.  The Role of the Possible Receptors and Intracellular Pathways in Protective Effect of Exogenous Anandamide in Kindling Model of Epilepsy.

Authors:  Sepideh Khaksar; Mona Salimi; Hadi Zeinoddini; Nima Naderi
Journal:  Neurochem Res       Date:  2022-02-03       Impact factor: 3.996

5.  Differential phosphoprotein signaling in the cortex in mouse models of Gulf War Illness using corticosterone and acetylcholinesterase inhibitors.

Authors:  Julia A Penatzer; Julie V Miller; Nicole Prince; Misa Shaw; Cayla Lynch; Mackenzie Newman; Gerald R Hobbs; Jonathan W Boyd
Journal:  Heliyon       Date:  2021-07-12

6.  Exploring the pathogenesis of canine epilepsy using a systems genetics method and implications for anti-epilepsy drug discovery.

Authors:  Ze-Jia Cui; Ye-Mao Liu; Qiang Zhu; Jingbo Xia; Hong-Yu Zhang
Journal:  Oncotarget       Date:  2017-12-27

7.  Deletion of FGF9 in GABAergic neurons causes epilepsy.

Authors:  Moran Guo; Can Cui; Xueqin Song; Lijing Jia; Duan Li; Xiuli Wang; Hui Dong; Yanqin Ma; Yaling Liu; Zhiqiang Cui; Le Yi; Zhongyao Li; Yue Bi; Yuanyuan Li; Yakun Liu; Weisong Duan; Chunyan Li
Journal:  Cell Death Dis       Date:  2021-02-19       Impact factor: 8.469

8.  Src/CK2/PTEN-Mediated GluN2B and CREB Dephosphorylations Regulate the Responsiveness to AMPA Receptor Antagonists in Chronic Epilepsy Rats.

Authors:  Ji-Eun Kim; Duk-Shin Lee; Hana Park; Tae-Cheon Kang
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

9.  PKA-RIIβ autophosphorylation modulates PKA activity and seizure phenotypes in mice.

Authors:  Jingliang Zhang; Chenyu Zhang; Xiaoling Chen; Bingwei Wang; Weining Ma; Yang Yang; Ruimao Zheng; Zhuo Huang
Journal:  Commun Biol       Date:  2021-03-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.